Answers are grounded in this paper and cite their sources.
Comprehensive cancer genomic profiling tests have recently been used clinically to guide optimal treatment. Currently approved tests use DNA from tissue or plasma samples to analyze a few hundred genes. RNA panels complement DNA panels to detect fusion and exon skipping.
No takes yet. Share an insight, caveat, or question.
Kage et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: